UK’s leading patient remote monitoring solutions and virtual ward startup Doccla has secured 45.9 million (£35M) in a series B funding round to expand services in the life science sector in Europe.
Co-founded in 2019 by Dag Larsson and Martin Ratz, the company provides at-home patient monitoring solutions that shift patients’ recovery process from hospitals to their homes.
Doccla’s series B funding round was spearheaded by Lakestar, with a significant contribution from Elaia, and the existing investors, including General Catalyst, which spearheaded the company’s series A round back in 2022, Speedinvest, and Bertelsmann Investments.
The patient monitoring startup will use the additional capital to expand virtual ward plans across Europe, particularly in Germany, France, Switzerland, and Austria.
Already used by the NHS, the company onboards patients at their homes with the necessary monitoring equipment and their assigned team of mobile doctors and nurses to begin the monitoring process.
When the patients’ recovery process is stable, the company’s team of healthcare professionals begins the offboarding process, which allows the patients to receive better healthcare services at home, lowering the overall care cost.
Doccla’s virtual at-home wards allow patients to be discharged from healthcare facilities early, freeing up resources for more people and providing the released patient with a comfortable recovery environment.
Recently, the company partnered with HSE in Ireland, extending its services to more patients across the UK and European countries.
